Abstract
In the first part of this document, we will present a theoretical aspect into the market for medicines that represents around 1.2 billion people worldwide. We will describe the process of entering each market. Each drug is marketed in a very specific way, involves governmental approval after a series of tests and legal issues. In the second part, we will focus more on the market entry issues on a more practical aspect. After presenting the link between obesity/overweight and cardiovascular pathologies, we will explore the means to raise awareness in our three main market targets and also scrutinize the common risks in each of them.
